PYRIDINYLAMINES

Described are pyridinylamines and pharmaceutically acceptable salts thereof, the use of these pyridinylamines for the prophylaxis and/or treatment of various diseases such as infectious diseases, including opportunistic infections, prion diseases, immunological diseases, autoimmune diseases, bipolar...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SAVIC, VLADIMIR, EICKHOFF, JAN, EIKE, LE, JOELLE, COTTON, MATTHEW, SHERBORNE, BRAD, ZECH, BIRGIT, HARRIS, JOHN, SCHWAB, WILFRIED, KLEBL, BERT, MATTHIAS, HAFENBRADL, DORIS, MUELLER, STEFAN, MACRITCHIE, JACKIE
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	SAVIC, VLADIMIR EICKHOFF, JAN, EIKE LE, JOELLE COTTON, MATTHEW SHERBORNE, BRAD ZECH, BIRGIT HARRIS, JOHN SCHWAB, WILFRIED KLEBL, BERT, MATTHIAS HAFENBRADL, DORIS MUELLER, STEFAN MACRITCHIE, JACKIE
description	Described are pyridinylamines and pharmaceutically acceptable salts thereof, the use of these pyridinylamines for the prophylaxis and/or treatment of various diseases such as infectious diseases, including opportunistic infections, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, as well as pharmaceutical compositions containing at least one pyridinylamine and/or pharmaceutically acceptable salts thereof. Furthermore, reaction procedures for the synthesis of the pyridinylamines are disclosed. La présente invention a trait à des pyridinylamines et leurs sels pharmaceutiquement acceptables, l'utilisation de ces pyridinylamines pour la prophylaxie et/ou le traitement de diverses maladies telles que des maladies infectieuses, comprenant des infections opportunistes, des maladies à prion, des maladies immunologiques, des maladies auto-immunes, des troubles bipolaires et cliniques, des maladies cardio-vasculaires, des maladies de prolifération cellulaire, le diabète, l'inflammation, les rejets de transplantation, le dysfonctionnement érectile, les maladies neurodégénératives et l'accident vasculaire cérébral, ainsi qu'à des compositions pharmaceutiques contenant au moins une pyridinylamine et/ou des sels acceptable de celle-ci. L'invention a également trait à des procédés de réaction pour la synthèse des pyridinylamines.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2006010637A8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2006010637A8</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2006010637A83</originalsourceid><addsrcrecordid>eNrjZOAPiAzydPH0i_Rx9PX0cw3mYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBgZmBoYGZsbmjhbGxKkCAHSSHmc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRIDINYLAMINES</title><source>esp@cenet</source><creator>SAVIC, VLADIMIR ; EICKHOFF, JAN, EIKE ; LE, JOELLE ; COTTON, MATTHEW ; SHERBORNE, BRAD ; ZECH, BIRGIT ; HARRIS, JOHN ; SCHWAB, WILFRIED ; KLEBL, BERT, MATTHIAS ; HAFENBRADL, DORIS ; MUELLER, STEFAN ; MACRITCHIE, JACKIE</creator><creatorcontrib>SAVIC, VLADIMIR ; EICKHOFF, JAN, EIKE ; LE, JOELLE ; COTTON, MATTHEW ; SHERBORNE, BRAD ; ZECH, BIRGIT ; HARRIS, JOHN ; SCHWAB, WILFRIED ; KLEBL, BERT, MATTHIAS ; HAFENBRADL, DORIS ; MUELLER, STEFAN ; MACRITCHIE, JACKIE</creatorcontrib><description>Described are pyridinylamines and pharmaceutically acceptable salts thereof, the use of these pyridinylamines for the prophylaxis and/or treatment of various diseases such as infectious diseases, including opportunistic infections, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, as well as pharmaceutical compositions containing at least one pyridinylamine and/or pharmaceutically acceptable salts thereof. Furthermore, reaction procedures for the synthesis of the pyridinylamines are disclosed. La présente invention a trait à des pyridinylamines et leurs sels pharmaceutiquement acceptables, l'utilisation de ces pyridinylamines pour la prophylaxie et/ou le traitement de diverses maladies telles que des maladies infectieuses, comprenant des infections opportunistes, des maladies à prion, des maladies immunologiques, des maladies auto-immunes, des troubles bipolaires et cliniques, des maladies cardio-vasculaires, des maladies de prolifération cellulaire, le diabète, l'inflammation, les rejets de transplantation, le dysfonctionnement érectile, les maladies neurodégénératives et l'accident vasculaire cérébral, ainsi qu'à des compositions pharmaceutiques contenant au moins une pyridinylamine et/ou des sels acceptable de celle-ci. L'invention a également trait à des procédés de réaction pour la synthèse des pyridinylamines.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070607&DB=EPODOC&CC=WO&NR=2006010637A8$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070607&DB=EPODOC&CC=WO&NR=2006010637A8$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SAVIC, VLADIMIR</creatorcontrib><creatorcontrib>EICKHOFF, JAN, EIKE</creatorcontrib><creatorcontrib>LE, JOELLE</creatorcontrib><creatorcontrib>COTTON, MATTHEW</creatorcontrib><creatorcontrib>SHERBORNE, BRAD</creatorcontrib><creatorcontrib>ZECH, BIRGIT</creatorcontrib><creatorcontrib>HARRIS, JOHN</creatorcontrib><creatorcontrib>SCHWAB, WILFRIED</creatorcontrib><creatorcontrib>KLEBL, BERT, MATTHIAS</creatorcontrib><creatorcontrib>HAFENBRADL, DORIS</creatorcontrib><creatorcontrib>MUELLER, STEFAN</creatorcontrib><creatorcontrib>MACRITCHIE, JACKIE</creatorcontrib><title>PYRIDINYLAMINES</title><description>Described are pyridinylamines and pharmaceutically acceptable salts thereof, the use of these pyridinylamines for the prophylaxis and/or treatment of various diseases such as infectious diseases, including opportunistic infections, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, as well as pharmaceutical compositions containing at least one pyridinylamine and/or pharmaceutically acceptable salts thereof. Furthermore, reaction procedures for the synthesis of the pyridinylamines are disclosed. La présente invention a trait à des pyridinylamines et leurs sels pharmaceutiquement acceptables, l'utilisation de ces pyridinylamines pour la prophylaxie et/ou le traitement de diverses maladies telles que des maladies infectieuses, comprenant des infections opportunistes, des maladies à prion, des maladies immunologiques, des maladies auto-immunes, des troubles bipolaires et cliniques, des maladies cardio-vasculaires, des maladies de prolifération cellulaire, le diabète, l'inflammation, les rejets de transplantation, le dysfonctionnement érectile, les maladies neurodégénératives et l'accident vasculaire cérébral, ainsi qu'à des compositions pharmaceutiques contenant au moins une pyridinylamine et/ou des sels acceptable de celle-ci. L'invention a également trait à des procédés de réaction pour la synthèse des pyridinylamines.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOAPiAzydPH0i_Rx9PX0cw3mYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBgZmBoYGZsbmjhbGxKkCAHSSHmc</recordid><startdate>20070607</startdate><enddate>20070607</enddate><creator>SAVIC, VLADIMIR</creator><creator>EICKHOFF, JAN, EIKE</creator><creator>LE, JOELLE</creator><creator>COTTON, MATTHEW</creator><creator>SHERBORNE, BRAD</creator><creator>ZECH, BIRGIT</creator><creator>HARRIS, JOHN</creator><creator>SCHWAB, WILFRIED</creator><creator>KLEBL, BERT, MATTHIAS</creator><creator>HAFENBRADL, DORIS</creator><creator>MUELLER, STEFAN</creator><creator>MACRITCHIE, JACKIE</creator><scope>EVB</scope></search><sort><creationdate>20070607</creationdate><title>PYRIDINYLAMINES</title><author>SAVIC, VLADIMIR ; EICKHOFF, JAN, EIKE ; LE, JOELLE ; COTTON, MATTHEW ; SHERBORNE, BRAD ; ZECH, BIRGIT ; HARRIS, JOHN ; SCHWAB, WILFRIED ; KLEBL, BERT, MATTHIAS ; HAFENBRADL, DORIS ; MUELLER, STEFAN ; MACRITCHIE, JACKIE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2006010637A83</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>SAVIC, VLADIMIR</creatorcontrib><creatorcontrib>EICKHOFF, JAN, EIKE</creatorcontrib><creatorcontrib>LE, JOELLE</creatorcontrib><creatorcontrib>COTTON, MATTHEW</creatorcontrib><creatorcontrib>SHERBORNE, BRAD</creatorcontrib><creatorcontrib>ZECH, BIRGIT</creatorcontrib><creatorcontrib>HARRIS, JOHN</creatorcontrib><creatorcontrib>SCHWAB, WILFRIED</creatorcontrib><creatorcontrib>KLEBL, BERT, MATTHIAS</creatorcontrib><creatorcontrib>HAFENBRADL, DORIS</creatorcontrib><creatorcontrib>MUELLER, STEFAN</creatorcontrib><creatorcontrib>MACRITCHIE, JACKIE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SAVIC, VLADIMIR</au><au>EICKHOFF, JAN, EIKE</au><au>LE, JOELLE</au><au>COTTON, MATTHEW</au><au>SHERBORNE, BRAD</au><au>ZECH, BIRGIT</au><au>HARRIS, JOHN</au><au>SCHWAB, WILFRIED</au><au>KLEBL, BERT, MATTHIAS</au><au>HAFENBRADL, DORIS</au><au>MUELLER, STEFAN</au><au>MACRITCHIE, JACKIE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRIDINYLAMINES</title><date>2007-06-07</date><risdate>2007</risdate><abstract>Described are pyridinylamines and pharmaceutically acceptable salts thereof, the use of these pyridinylamines for the prophylaxis and/or treatment of various diseases such as infectious diseases, including opportunistic infections, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, as well as pharmaceutical compositions containing at least one pyridinylamine and/or pharmaceutically acceptable salts thereof. Furthermore, reaction procedures for the synthesis of the pyridinylamines are disclosed. La présente invention a trait à des pyridinylamines et leurs sels pharmaceutiquement acceptables, l'utilisation de ces pyridinylamines pour la prophylaxie et/ou le traitement de diverses maladies telles que des maladies infectieuses, comprenant des infections opportunistes, des maladies à prion, des maladies immunologiques, des maladies auto-immunes, des troubles bipolaires et cliniques, des maladies cardio-vasculaires, des maladies de prolifération cellulaire, le diabète, l'inflammation, les rejets de transplantation, le dysfonctionnement érectile, les maladies neurodégénératives et l'accident vasculaire cérébral, ainsi qu'à des compositions pharmaceutiques contenant au moins une pyridinylamine et/ou des sels acceptable de celle-ci. L'invention a également trait à des procédés de réaction pour la synthèse des pyridinylamines.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre
recordid	cdi_epo_espacenet_WO2006010637A8
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
title	PYRIDINYLAMINES
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T23%3A10%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SAVIC,%20VLADIMIR&rft.date=2007-06-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2006010637A8%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true